Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 29, 2015 5:07 PM ET

Biotechnology

Company Overview of Alexion Pharmaceuticals, Inc.

Key Executives for Alexion Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David L. Hallal 9 RelationshipsChief Executive Officer and Director48
Leonard Bell M.D.9 RelationshipsCo-Founder, Chairman of The Board and Consultant56
Joseph A. Madri Ph.D., M.D.No RelationshipsCo-Founder67
Vikas Sinha M.B.A., C.A., CPANo RelationshipsChief Financial Officer and Executive Vice President51
Frank J. Wright No RelationshipsSenior Vice President and President of Alexion Pharma International Sàrl66
View More Key Executives

Alexion Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Leonard Bell M.D. 9 RelationshipsAlexion Pharmaceuticals, Inc.56
David L. Hallal 9 RelationshipsAlexion Pharmaceuticals, Inc.48
R. Douglas Norby 49 RelationshipsMagnaChip Semiconductor Corporation78
Alvin S. Parven 9 RelationshipsAlexion Pharmaceuticals, Inc.74
Andreas Rummelt Ph.D. 23 RelationshipsInterPharmaLink AG58
View All Board Members

Alexion Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee R. Douglas Norby49 Relationships3 Executives
Compensation Committee Alvin S. Parven9 Relationships3 Executives
Nominating Committee J.D.Ann M. Veneman51 Relationships3 Executives
Corporate Governance Committee J.D.Ann M. Veneman51 Relationships3 Executives
Finance Committee R. Douglas Norby49 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$696.1K
696.1K
375.1K
Bonus
Not meaningful
Total Short Term Compensation$48.2M
Not meaningful
Total Value of Options$696.1K
696.1K
30.8M
Compensation as of Fiscal Year 2014
Alexion Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

GP Batteries International Limited Announces Executive Appointments
May 28, 2015 9:15 AM ET
HRG Group, Inc. Announces Resignation of Michael Sena as Senior Vice President and Chief Accounting Officer
May 27, 2015 8:41 PM ET
Timo Hiekkaranta to Leave Suominen Corporation
May 27, 2015 6:00 AM ET
The Clorox Company Announces Board Changes
May 15, 2015 12:46 PM ET
Ryan Announces Executive Changes
May 13, 2015 4:55 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alexion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.